Up to 40% of individuals with IBD may experience extraintestinal manifestations of the disease. Are you familiar with the common extraintestinal manifestations among these patients? Take the pop quiz to...
Risk factors for pseudogout include older age, joint trauma, genetic disorder, mineral imbalances, an underactive thyroid gland, or an overactive parathyroid gland. Do you know which joint is most impacted...
The American College of Rheumatology Guideline for the Management of Gout recommends urate-lowering therapy (ULT) as first-line therapy for patients with gout. Do you know which specific therapeutic agent...
A recent study examines factors influencing the achievement of serum urate (SU) goals in patients with gout receiving treat-to-target urate-lowering therapy. Can you identify a key determinant of SU goal...
